Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Restaurant Industry News Triton Pacific Capital expands QSR portfolio with acquisition of 64-unit KFC portfolio Triton Pacific Capital Partners, a distinguished private equity firm, through its affiliate Tasty Chick’n, has successfully acquired a… byPallavi MadhirajuMay 21, 2024